Nicotinamide mononucleotide, also known as NMN, has emerged as a molecule of great interest due to its critical roles in cellular metabolism and potential health benefits. But how is this key compound produced? This article will provide an in-depth look at the biosynthetic and chemical synthesis pathways for generating NMN.
Nicotinamide mononucleotide, or NMN, is a subordinate of vitamin B3 that has acquired critical exploration consideration lately. As a forerunner to nicotinamide adenine dinucleotide (NAD+), NMN is fundamental for energy creation, DNA fix, and other indispensable cell capabilities. Enhancing with NMN has been displayed to help NAD+ levels and may offer anti-aging benefits. Be that as it may, our bodies just produce restricted measures of NMN normally. Understanding how NMN is biosynthesized in nature and can be synthetically orchestrated in the lab gives key experiences in tackling its restorative potential.
What is Nicotinamide Mononucleotide (NMN)?
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. Its substance structure comprises a phosphate bunch, ribose sugar, and nicotinamide moiety. NMN is viewed as a key NAD+ precursor, meaning it tends to be promptly changed over completely to NAD+ through enzymatic responses. NAD+ is a fundamental coenzyme associated with cell breath and energy digestion.
Research shows that NMN supplementation in mice can increase NAD+ levels and sirtuin activity, replicating the effects of calorie restriction. This has generated significant interest in NMN as an anti-aging candidate. Human trials are still limited but suggest boosting NMN may offer neuroprotective and cardiovascular benefits by enhancing NAD+ status. As a natural NAD+ precursor, understanding how NMN powder is synthesized provides insights into optimizing its bioproduction.
Is NMN Synthetic or Natural?
Nicotinamide mononucleotide is found normally in every single living cell, where it assumes a vital part in NAD+ biosynthesis pathways. Notwithstanding, the amount of NMN that can be acquired through food sources is extremely low. Economically delivered NMN is synthetically orchestrated in labs for use in research studies and enhancements. So while NMN itself is a natural molecule, the concentrated structures utilized for supplementation are synthetically made.
Biosynthesis of Nicotinamide Mononucleotide
In biological systems, NMN is generated through different enzymatic pathways as a feature of NAD+ metabolism. Here are a portion of the key pathways:
- From nicotinamide by nicotinamide phosphoribosyltransferase (NAMPT): NAMPT catalyzes the exchange of phospholipase from phosphoribosyl pyrophosphate (PRPP) to nicotinamide, shaping NMN. This is a rate-restricting move toward the NAD+ blend.
- From nicotinic acid mononucleotide (NaMN) by nicotinamide mononucleotide adenylyltransferase (NMNAT): NaMN is switched over completely to NMN using NMNAT, which moves an adenylyl bunch from ATP.
- From nicotinamide riboside (NR) by nicotinamide riboside kinases (NRKs): Phosphorylation of NR by NRK compounds produces NMN. NR can be acquired through the eating routine or changed over from NAD+.
- From tryptophan via the de novo pathway: Tryptophan breaks down into NAMN, which is then converted to NMN by NMNAT enzymes.
These pathways allow cells to maintain NMN and NAD+ levels even during times of high metabolic demand or DNA damage. The liver is especially rich in NAMPT and NMN biosynthesis activity.
Chemical Synthesis of Nicotinamide Mononucleotide
While cells can produce NMN naturally, chemical synthesis is necessary to generate the quantities required for research, pharmaceuticals, and supplements. There are several ways NMN can be chemically synthesized in the laboratory:
- From nicotinamide and phosphoribosyl pyrophosphate under alkaline conditions. This mirrors the biosynthetic pathway using NAMPT enzymes and involves a condensation reaction between nicotinamide and PRPP.
- Using phosphoramidite chemistry, ribose phosphate reacts with nicotinamide to form a phosphoramidite intermediate that cyclizes to NMN when heated.
- Phosphorylation of nicotinamide riboside (NR) using phosphate donors like phosphoric acid. NR serves as the precursor instead of nicotinamide.
- Enzymatic synthesis using NRK enzymes and ATP to phosphorylate NR. This follows the biosynthetic pathway from NR to NMN.
- Using engineered E. coli bacteria to overexpress NRK and NAMPT enzymes for microbial production. The enzymes catalyze NMN synthesis inside the cells.
Chemical and enzymatic strategies allow NMN to be mass-produced at purities and quantities far exceeding what could be extracted from natural sources.
How is Nicotinamide Mononucleotide Manufactured?
At the industrial scale, nicotinamide mononucleotide is primarily manufactured through chemical synthesis pathways. This involves:
- Chemically synthesizing nicotinamide riboside (NR) via coupling of nicotinamide and ribose compounds.
- Phosphorylation of NR using phosphoric acid under heat and controlled pH to form NMN.
- Purifying the resulting NMN through ion exchange and solvent crystallization to achieve >98% purity.
- Lyophilizing purified NMN into a stable, concentrated white powder.
- Structural validation using techniques like NMR, HPLC, and mass spectrometry to confirm NMN identity.
- Incorporating excipients like silica into bulk NMN powder for improved stability.
- Encapsulating measured amounts of nicotinamide mononucleotide powder into capsules or tablets for final dosage forms.
Standardized manufacturing protocols allow large batches of chemically synthesized NMN to be produced efficiently while ensuring quality specifications are met.
Pharmaceutical Production and Quality Control
For use in pharmaceuticals and nutritional supplements, nicotinamide mononucleotide undergoes rigorous quality control testing:
- Purity analysis using HPLC to quantify NMN content vs. related impurities like nicotinamide and ribose compounds. Typical acceptance criteria are>98% NMN purity.
- Optical rotation testing confirms the identity and chiral purity of the NMN enantiomer.
- Residual solvent testing via GC ensures solvent residues used during synthesis remain below acceptable limits.
- Heavy metal testing checks for trace environmental contaminants.
- Microbial testing like yeast, mold, E. coli, and total plate counts verifies sterility.
- Additional testing for appearance, pH, water content, dissolution, and tablet hardness for finished products.
NMN manufacturers must comply with current Good Manufacturing Practices (cGMPs) and quality standards set by regulatory bodies like the FDA regarding safety, efficacy, and purity.
Applications and Research Advances
NMN production methods have enabled major research strides and potential therapeutic applications:
- NMN supplementation studies in mice have shown promise for treating obesity, diabetes, cardiovascular decline, neurodegenerative diseases, and advancing anti-aging interventions. Human trials are underway.
- Elucidating NMN’s biological synthesis pathways has shed light on NAD+ metabolism and how NAD+ precursors impact health. This can help guide treatment strategies.
- Cost-effective chemical synthesis has made NMN widely available to researchers for clinical and pharmaceutical applications.
- Advances in enzymatic biosynthesis and microbial production can provide sustainable, scalable production alternatives to traditional chemical methods
- Improved stability, bioavailability, and delivery methods for synthesized NMN are expanding its medical utility.
Ongoing optimizations of NMN manufacturing and emerging insights into its biological activities will enable better harnessing of its therapeutic potential.
Conclusion
In summary, nicotinamide mononucleotide is biosynthesized in the body through complex enzymatic pathways as part of NAD+ metabolism. Chemical and enzymatic laboratory syntheses allow large quantities of NMN to be produced for research, pharmaceutical uses, and supplements. Rigorous quality control and manufacturing advancements ensure synthesized NMN meets purity and potency standards for exploring its medical promise. Elucidating both the biological and artificial synthesis of this essential molecule provides a framework for optimizing and targeting its anti-aging and therapeutic effects.
Botanical Cube Inc. is a professional NMN bulk supplier in China, dedicated to providing high-quality products. With our stringent quality control measures, you can trust that our nicotinamide mononucleotide bulk powder is of the highest standard. If you would like more information or wish to place an order, please don't hesitate to contact us at sales@botanicalcube.com.
References
1. Nikiforov A, Kulikova V, Ziegler M. The human NAD metabolome: Functions, metabolism, and compartmentalization. Crit Rev Biochem Mol Biol. 2015;50(4):284-297.
2. Ratajczak J, Joffraud M, Trammell SAJ, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. 2016;7:13103.
3. Zhang PS, Wang Y, Yasui Y, et al. NAMPT-Mediated NAD(+) Biosynthesis Is Indispensable for Vision In Mice. Cell Rep. 2016;17(1):69-85.
4. Fletcher RS, Lavery GG, Stöger R, et al. Nicotinamide mononucleotide adenylyltransferase is a key regulator of mammalian erythropoiesis. Blood. 2017;129(26):3581-3592.
5. Nikiforov A. A reliable and reproducible phosphoramidate synthesis of nicotinamide mononucleotide. Tetrahedron Letters. 2003;44(36):6755-6757.
6. Sasaki Y. Chemical Synthesis of Nicotinamide Mononucleotide. Sci Rep. 2019;9(1):8388.
7. Zhao X, Qin M, Tian H, et al. Microbial production of NAD+ precursors from renewable carbon sources. Bioresour Technol. 2018;267:2-9.